{{Rsnum
|rsid=2301753
|Gene=RNF39
|Chromosome=6
|position=30071463
|Orientation=minus
|GMAF=0.1846
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=RNF39
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 0.9 | 15.7 | 83.3
| HCB | 2.2 | 37.8 | 60.0
| JPT | 9.0 | 47.7 | 43.2
| YRI | 4.8 | 49.2 | 46.0
| ASW | 3.6 | 56.4 | 40.0
| CHB | 2.2 | 37.8 | 60.0
| CHD | 5.8 | 21.2 | 73.1
| GIH | 2.0 | 21.4 | 76.5
| LWK | 6.5 | 43.9 | 49.5
| MEX | 0.0 | 0.0 | 0.0
| MKK | 6.5 | 43.2 | 50.3
| TSI | 1.0 | 35.7 | 63.3
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs2301753
|Name_s=
|Gene_s=PPP1R11, RNF39
|Feature=
|Evidence=PubMed ID:17641165
|Annotation=This variant is associated with low HIV viral load and disease progression.
|Drugs=
|Drug Classes=
|Diseases=HIV; HIV Infections
|Curation Level=Curated
|PharmGKB Accession ID=PA162316696
}}

{{PMID Auto
|PMID=18495769
|Title=Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressor.
|OA=1
}}

{{PMID Auto
|PMID=18982067
|Title=HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles.
|OA=1
}}

{{PMID Auto
|PMID=20041166
|Title=Common genetic variation and the control of HIV-1 in humans.
|OA=1
}}

{{GET Evidence
|gene=RNF39
|aa_change=Ala304Glu
|aa_change_short=A304E
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2301753
|overall_frequency_n=1294
|overall_frequency_d=7478
|overall_frequency=0.173041
|n_genomes=20
|n_genomes_annotated=0
|n_haplomes=24
|n_articles=1
|n_articles_annotated=1
|in_pharmgkb=Y
|nblosum100=3
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}